Monte Rosa Therapeutics, Inc. (GLUE)

$17.13 +3.5%

EARNINGS ANALYTICS

event_upcoming Est. Next Earnings: 2026-08-07 ESTIMATED

Across 20 earnings reports since Aug 12, 2021, Monte Rosa Therapeutics, Inc. (GLUE) has a clear post-earnings pattern. It moves ±6.26% on average after reporting and finishes higher 50.0% of the time. Its largest post-earnings gain was +16.33% (Mar 29, 2022) and its largest decline was -16.03% (May 11, 2022). The next earnings report is predicted for 2026-08-07 (estimated).

Earnings Price Reaction

Scroll to zoom, drag to pan — click earnings dots for details

Beat Miss

Earnings Impact

Total Earnings

Avg Abs. Movement

±6.26%

Positive %

50.0%

Negative %

50.0%

Historical Earnings Statistics

Date	Timing	Open	High	Close	Volume	Movement %	SEC Filing
May 07, 2026	☀ PRE	$20.22	$20.22	$19.81	36,929	-2.73%	open_in_new
Mar 17, 2026	☀ PRE	$16.14	$16.77	$16.03	1,185,500	-1.96%	open_in_new
Nov 06, 2025	☀ PRE	$12.40	$13.59	$13.01	1,549,300	+5.69%	open_in_new
Aug 07, 2025	☀ PRE	$4.37	$4.37	$4.23	426,900	-2.87%	open_in_new
May 08, 2025	☀ PRE	$4.57	$4.62	$4.22	671,500	+9.61%	open_in_new
Mar 20, 2025	☀ PRE	$6.46	$7.31	$7.06	2,475,200	+5.37%	open_in_new
Nov 07, 2024	☀ PRE	$9.50	$9.85	$9.53	1,131,200	+0.85%	open_in_new
Aug 08, 2024	☀ PRE	$3.84	$3.99	$3.98	171,900	+10.25%	open_in_new
May 09, 2024	☀ PRE	$5.24	$5.30	$5.18	241,200	-1.52%	open_in_new
Mar 14, 2024	☀ PRE	$6.55	$6.55	$6.09	147,900	-8.42%	open_in_new
Nov 09, 2023	☀ PRE	$3.67	$3.78	$3.30	167,600	-10.57%	open_in_new
Aug 10, 2023	☀ PRE	$6.87	$6.93	$6.68	214,500	-1.62%	open_in_new
May 11, 2023	☀ PRE	$5.99	$5.99	$5.85	84,300	+1.04%	open_in_new
Mar 16, 2023	☀ PRE	$6.37	$7.04	$7.01	116,800	+7.35%	open_in_new
Nov 10, 2022	☀ PRE	$7.87	$8.76	$8.00	142,100	+5.26%	open_in_new
Aug 11, 2022	☀ PRE	$9.44	$9.44	$9.16	482,300	+5.17%	open_in_new
May 11, 2022	☀ PRE	$9.57	$10.52	$7.91	208,400	-16.03%	open_in_new
Mar 29, 2022	☀ PRE	$11.01	$12.90	$12.68	204,100	+16.33%	open_in_new
Nov 12, 2021	☽ POST	$25.05	$26.50	$25.19	205,600	-8.69%	open_in_new
Aug 12, 2021	☀ PRE	$32.87	$34.36	$32.24	268,800	-3.88%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±6.26%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

SEC Filing Types

description SCHEDULE 13G/A

14 chevron_right

description CORRESP

8 chevron_right

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
144/A	20260602	open_in_new SEC.gov
4	20260602	open_in_new SEC.gov
144	20260601	open_in_new SEC.gov
4	20260601	open_in_new SEC.gov
144	20260529	open_in_new SEC.gov
4	20260528	open_in_new SEC.gov
144	20260527	open_in_new SEC.gov
4	20260526	open_in_new SEC.gov
144	20260522	open_in_new SEC.gov
4	20260522	open_in_new SEC.gov

Frequently asked about GLUE earnings

When does Monte Rosa Therapeutics, Inc. report earnings next? expand_more

Monte Rosa Therapeutics, Inc. (GLUE)'s next earnings date is estimated for 2026-08-07. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does GLUE stock move after earnings? expand_more

Over 20 reports, GLUE has moved an average of ±6.26% the session after earnings, closing higher 50.0% of the time.

What was GLUE's biggest post-earnings move? expand_more

GLUE's largest post-earnings gain on record was +16.33% on Mar 29, 2022, and its largest decline was -16.03% on May 11, 2022.

Where can I find Monte Rosa Therapeutics, Inc.'s SEC filings? expand_more

All of Monte Rosa Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.